1. Home
  2. MSC vs RGNX Comparison

MSC vs RGNX Comparison

Compare MSC & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSC

Studio City International Holdings Limited

HOLD

Current Price

$2.38

Market Cap

458.4M

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$6.33

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSC
RGNX
Founded
2000
2008
Country
Hong Kong
United States
Employees
5879
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
458.4M
528.6M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
MSC
RGNX
Price
$2.38
$6.33
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
5.9K
1.6M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
N/A
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$2.10
$5.46
52 Week High
$6.63
$16.19

Technical Indicators

Market Signals
Indicator
MSC
RGNX
Relative Strength Index (RSI) 45.34 35.84
Support Level $2.21 N/A
Resistance Level $3.30 $9.67
Average True Range (ATR) 0.21 0.78
MACD 0.00 -0.34
Stochastic Oscillator 19.39 15.33

Price Performance

Historical Comparison
MSC
RGNX

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: